Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedMarc Suárez‐Calvet, Natàlia Vilor‐Tejedor, Marta Milà‐Alomà et al.|EMBO Molecular Medicine|2020Cited by 411
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>Marta Milà‐Alomà, Gemma Salvadó, Juan Domingo Gispert et al.|Alzheimer s & Dementia|2020Cited by 260